Pfau, Maximilian
van Dijk, Elon H. C.
van Rijssen, Thomas J.
Schmitz-Valckenberg, Steffen
Holz, Frank G.
Fleckenstein, Monika
Boon, Camiel J. F.
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (PF 950/1-1)
Research to Prevent Blindness, New York, NY
Stichting Macula Fonds
Retina Nederland Onderzoek Fonds
Stichting Blinden-Penning
Algemene Nederlandse Vereniging ter Voorkoming van Blindheid
Landelijke Stichting voor Blinden en Slechtzienden
Stichting Steunfonds Uitzicht
Rotterdamse Stichting Blindenbelangen
Stichting Leids Oogheelkundig Ondersteuningsfonds
Haagse Stichting Blindenhulp
Stichting Ooglijders
Oxford NIHR Biomedical Research Center
Gisela Thier Fellowship of Leiden University
Netherlands Organisation for Scientific Research
Article History
Received: 13 April 2021
Accepted: 30 July 2021
First Online: 14 October 2021
Competing interests
: The Department of Ophthalmology, University of Bonn, received technical support from Heidelberg Engineering, Heidelberg, Germany, Carl Zeiss Meditec, Jena, Germany, and Centervue, Padova, Italy. Maximilian Pfau, Elon H.C. van Dijk, Thomas J. van Rijssen, Monika Fleckenstein, Camiel J.F. Boon report no competing financial and/or non-financial interests in relation to the work described. F.G. Holz reports grants and personal fees from Acucela, Allergan, Apellis, Bayer, Bioeq/Formycon, Centervue, Roche/Genentech, Geuder, Heidelberg Engineering, ivericbio, Kanghong, Novartis, Zeiss; personal fees from Boehringer-Ingelheim, Grayburg Vision, LinBioscience, Pixium Vision, Stealth BioTherapeutics, Aerie. Dr. Schmitz-Valckenberg reports grants from Acucela/Kubota Vision, grants and personal fees from Allergan, personal fees from Bayer, non-financial support from Carl Zeiss MediTec, non-financial support from Centervue, personal fees from Gailmedix, personal fees and non-financial support from Heidelberg Engineering, grants from Katario, grants and personal fees from Novartis, grants and personal fees from Roche, personal fees from Oxurion, grants and personal fees from Bioeq/Formycon, personal fees from Apellis, grants from SparingVision, grants from Pixium, outside the submitted work.